Siegfried Holding AG operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Siegfried Holding AG with three other
pharmaceutical manufacturers in Europe:
sales of 569.31 million Euro [US$697.69 million]
(614.49 million Euro [US$753.05 million]
of which 51%
was Non-Proprietary Homeopathic Medicines), and
based in Germany
(553.10 million Euro [US$677.82 million]
of which 63%
Siegfried Holding AG reported sales of 717.73 million Swiss Francs (US$745.30 million)
December of 2016.
increase of 49.3%
versus 2015, when the company's sales were 480.57 million Swiss Francs.
Sales of Drug Substances saw an increase
67.4% in 2016, from
333.20 million Swiss Francs to 557.90 million Swiss Francs.